ERBB2 and small cell lung carcinoma: EGFR T790M has been identified as the most common mechanism of acquired resistance, and other, less frequent mechanisms have also been reported, including MET amplification, HER2 amplification, mutation of PIK3CA and BRAF, transformation to small-cell lung cancer and epithelial-to-mesenchymal transition30.